← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Second-generation cephalosporins
cefoxitin
J01DC01
Forms & Strengths
- Injectable powder for reconstitution: 1 g, 2 g, 10 g
Adult Dosing
- General infections: 1 g to 2 g IV every 6 to 8 hours
- Surgical prophylaxis: 2 g IV 30 to 60 minutes prior to surgery, then every 6 hours for up to 24 hours
Pediatric Dosing
- Neonates > 1 week: 20 to 40 mg/kg IV every 8 to 12 hours
- Pediatric patients >= 3 months: 80 to 160 mg/kg/day IV divided in 4 to 6 doses
Indications
- Peritonitis and intra-abdominal infections
- Pelvic inflammatory disease and female genital tract infections
- Lower respiratory tract infections
- Surgical prophylaxis in contaminated or potentially contaminated procedures
Mechanism of Action
- Second-generation cephalosporin bactericidal inhibitor of bacterial cell wall synthesis
- Resistant to many beta-lactamases and active against select anaerobes like Bacteroides fragilis
Contraindications
- Hypersensitivity to cefoxitin or other cephalosporin-class antibacterial drugs
- History of immediate anaphylactic reactions to penicillins
Adverse Reactions
- Diarrhea, including Clostridioides difficile-associated colitis
- Injection site reactions, pain, and thrombophlebitis
- Hypersensitivity reactions, rash, urticaria, pruritus
- Transient elevations in hepatic transaminases and BUN
Drug Interactions
- Probenecid competitively inhibits renal tubular secretion of cefoxitin
- Potential synergistic nephrotoxicity when co-administered with aminoglycosides
- May enhance the anticoagulant effect of vitamin K antagonists
Curated Content: Needs Vetting Before Put to Clinical Use